Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florea, V. G.
Right arrow Articles by Henein, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florea, V. G.
Right arrow Articles by Henein, M. Y.
(Chest. 2000;118:1063-1068.)
© 2000 American College of Chest Physicians

Right Ventricular Dysfunction in Adult Severe Cystic Fibrosis*

Viorel G. Florea, MD, PhD{dagger}; Natalia D. Florea, MD; Rakesh Sharma, BSc; Andrew J. S. Coats, DM; Derek G. Gibson, MD; Margaret E. Hodson, MD and Michael Y. Henein, MD, PhD

* From the Department of Cardiac Medicine (Drs. V.G. Florea, N.D. Florea, Coats, Gibson, and Henein and Mr. Sharma), National Heart and Lung Institute, London, UK; and the Department of Cystic Fibrosis (Dr. Hodson), Royal Brompton Hospital, London, UK. {dagger} Currently at Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN.

Correspondence to: Michael Y. Henein, MD, PhD, Department of Cardiac Medicine, National Heart and Lung Institute, London, SW3 6LY, UK; e-mail: m.henein{at}rbh.nthames.nhs.uk

Study objectives: This study sought to assess the extent of impairment of cardiac function in adult patients with end-stage cystic fibrosis (CF) and to examine the relationship between cardiovascular abnormalities and the degree of hypoxemia and hypercapnia.

Design and setting: A retrospective study in a tertiary cardiac and CF center.

Participants and interventions: A total of 103 adult patients with end-stage CF awaiting lung or heart and lung transplantation (mean age [± SD], 26 ± 7 years; 54 men) underwent Doppler echocardiography and arterial blood gas analysis (mean PaO2, 54 ± 10 mm Hg; mean PaCO2, 47 ± 8 mm Hg). The findings were compared to those of 17 healthy control subjects (mean age, 24 ± 7 years; 13 men) who had no history of cardiac or pulmonary disease.

Measurements and results: All patients were in sinus rhythm with a mean tachycardia of 112 ± 18 beats/min (control subjects, 76 ± 16; p < 0.0001) and had a cardiac output of 5.3 L/min (control subjects, 4.3 L/min; p < 0.04). In the patient group, the left ventricular (LV) dimensions, systolic and diastolic function, and wall thickness were all within normal limits. The mean amplitude of long-axis excursion in patients was normal at the LV site, but that of the right ventricular (RV) free wall was significantly reduced as compared with control subjects (1.6 ± 0.4 vs 2.2 ± 0.4 cm, respectively; p < 0.001), which was found to correlate with the degree of hypoxemia (r = 0.63; p < 0.02) and hypercapnia (r = -0.68; p < 0.01). RV diastolic function, which was represented by the relative isovolumic relaxation time to cardiac cycle length, was longer in patients than in control subjects (8.7 ± 4.8% vs 5.0 ± 3.0%, respectively; p < 0.03). The pulmonary flow acceleration time (90 ± 22 vs 121 ± 34 ms, respectively; p < 0.01) and the systolic stroke distance (7.0 ± 2.2 vs 10.5 ± 1.9 cm/s2; p < 0.001) were both lower than normal.

Conclusions: This study confirms the presence of significant RV systolic and diastolic dysfunction in the setting of consistent tachycardia and increased cardiac output in adult CF patients with severe disease. No specific LV abnormalities were detected in these patients.

Key Words: cystic fibrosis • echocardiography • right ventricular function




This article has been cited by other articles:


Home page
ChestHome page
A. H. Alzeer, A. F. Al-Mobeirek, H. A. K. Al-Otair, U. A. F. Elzamzamy, I. A. Joherjy, and A. S. Shaffi
Right and Left Ventricular Function and Pulmonary Artery Pressure in Patients With Bronchiectasis
Chest, February 1, 2008; 133(2): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Vitarelli, Y. Conde, E. Cimino, S. Stellato, S. D'Orazio, I. D'Angeli, B. L. Nguyen, V. Padella, F. Caranci, A. Petroianni, et al.
Assessment of right ventricular function by strain rate imaging in chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2006; 27(2): 268 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. Fauroux, N. Hart, S. Belfar, M. Boule, I. Tillous-Borde, D. Bonnet, E. Bingen, and A. Clement
Burkholderia cepacia Is Associated with Pulmonary Hypertension and Increased Mortality among Cystic Fibrosis Patients
J. Clin. Microbiol., December 1, 2004; 42(12): 5537 - 5541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.